Milatuzumab (hLL1, MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death.
Purity:
>99.0%
CAS Number:
[899796-83-9]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted